Platelet-derived growth factor and malignant transformation.
Platelet-derived growth factor and malignant transformation.
复制标题
血小板源性生长因子和恶性转化。
DOI:
10.1016/0006-2952(84)90202-8
复制
发表时间:
1984
影响因子:
5.8
通讯作者:
Antoniades,HN
中科院分区:
文献类型:
--
作者:
Antoniades,HN
Investigations of human platelet-derived growth factor (PDGF), a potent mitogen for mesenchymal derived cells in culture [l-3], have provided a rational basis for the understanding of at least one mechanism involved in malignant transformation. PDGF is a heat-stable(loo”), cationic (isolectric point 9.8) polypeptide[4] that circulates in blood stored in the a-granules of platelets [5]. It is released from platelets into the serum during blood clotting, constituting the major polypeptide growth factor of serum. It is suggested that in uiuo PDGF is delivered during platelet degranulation at the site of injury where it participates in the process of wound healing by stimulating the proliferation and migration of connective tissue cells.We have shown recently that PDGF and the transforming protein of the simian sarcoma virus (SSV). an acute transforming retrovirus of primate origin, derive from the same or closely related cellular genes [6]. This conclusion is based on the demonstration that PDGF and the SSV transforming protein [7, 8] share extensive amino acid sequence homology 16, 9, 101, have common antigenic determinants and structural conformation[111, and exert identical biological functions [12, 131. These findings suggest that the ability of the simian sarcoma virus to induce transformation derives from the incorporation of the PDGF gene within the retroviral genome. The resulting transforming one gene (v-sis) region within the retrovirus genome codes for a PDGF-like mitogen and is capable of inducing neoplastic transformation by the continuous production of this potent mitogen causing sustained cell proliferation.